205047-49-0Relevant articles and documents
Design and synthesis of monocyclic β-lactams as mechanism-based inhibitors of human cytomegalovirus protease
Borthwick, Alan D.,Weingarten, Gordon,Haley, Terry M.,Tomaszewski, Mirek,Wang, Wei,Hu, Zhouhan,Bedard, Jean,Jin, Haloun,Yuen, Leonard,Mansour, Tarek S.
, p. 365 - 370 (2007/10/03)
Mechanism based inhibitors of HCMV protease have been designed based on the monocyclic β-lactam nucleus, which have been shown to acylate the viral enzyme in a time dependant manner. SAR in a series of monocyclic β-lactam N-ureas, has defined the size and relative stereochemisty of the C-3 substituent producing a low micromolar inhibitor 17b with good aqueous stability and selectivity over the mammalian serine proteases.